ReviewInternational immunopharmacology2021

Immunotherapy of multisystem inflammatory syndrome in children (MIS-C) following COVID-19 through mesenchymal stem cells.

Wanich Suksatan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.